These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 1968221)

  • 1. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP; Downes HF; Mirski SE; Clements DJ
    Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
    Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
    Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
    Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
    Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
    Mirski SE; Gerlach JH; Cole SP
    Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
    Campling BG; Baer K; Baker HM; Lam YM; Cole SP
    Br J Cancer; 1993 Aug; 68(2):327-35. PubMed ID: 8102244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
    Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line.
    Feldhoff PW; Mirski SE; Cole SP; Sullivan DM
    Cancer Res; 1994 Feb; 54(3):756-62. PubMed ID: 8306338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
    Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
    Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    Townsend AJ; Tu CP; Cowan KH
    Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
    Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.
    Mirski SE; Cole SP
    Cancer Res; 1989 Oct; 49(20):5719-24. PubMed ID: 2571409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
    Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
    Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.